Trademark: 87608501
Status Date
Tuesday, June 26, 2018
Registration Number
5501132
Registration Date
Tuesday, June 26, 2018
Filing Date
Thursday, September 14, 2017
Published for Opposition
Tuesday, April 10, 2018
5 pharmaceutical preparations for the treatment of leukemia, other cancers, and auto-immune diseases; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system
The mark consists of an arc design with orange at the top, yellow in the middle and black at the bottom.
The color(s) black, yellow and orange is/are claimed as a feature of the mark.
Jun 26, 2023
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Dec 9, 2022
Applicant/Correspondence Changes (Non-Responsive) Entered
Dec 9, 2022
Teas Change Of Correspondence Received
Dec 9, 2022
Teas Withdrawal Of Attorney Received-Firm Retains
Dec 9, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Dec 9, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Dec 9, 2022
Teas Change Of Owner Address Received
Jun 26, 2018
Registered-Principal Register
Apr 10, 2018
Official Gazette Publication Confirmation E-Mailed
Apr 10, 2018
Published For Opposition
Mar 21, 2018
Notification Of Notice Of Publication E-Mailed
Mar 8, 2018
Assigned To Lie
Mar 2, 2018
Approved For Pub - Principal Register
Feb 26, 2018
Teas/Email Correspondence Entered
Feb 26, 2018
Correspondence Received In Law Office
Feb 26, 2018
Teas Response To Office Action Received
Nov 28, 2017
Notification Of Non-Final Action E-Mailed
Nov 28, 2017
Non-Final Action E-Mailed
Nov 28, 2017
Non-Final Action Written
Nov 21, 2017
Assigned To Examiner
Sep 21, 2017
Notice Of Design Search Code E-Mailed
Sep 20, 2017
New Application Office Supplied Data Entered
Sep 18, 2017
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
